Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy - Wikidata - awgldk - TriplyDB

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy

http://www.wikidata.org/entity/Q28216997

about

sameAs

Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy Shared genetic causes of cardiac hypertrophy in children and adults Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives Thin filament mutations: developing an integrative approach to a complex disorder Combinatorial effects of double cardiomyopathy mutant alleles in rodent myocytes: a predictive cellular model of myofilament dysregulation in disease Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers.Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy Genetic testing for potentially lethal, highly treatable inherited cardiomyopathies/channelopathies in clinical practice.Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis.Genetics of inherited cardiomyopathy.Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.Genetic basis of hypertrophic cardiomyopathy.Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.Mutations in the cardiac troponin T gene show various prognoses in Japanese patients with hypertrophic cardiomyopathy Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.TNNT1, TNNT2, and TNNT3: Isoform genes, regulation, and structure-function relationships.A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium.Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility.Serial observations and mutational analysis of an adoptee with family history of hypertrophic cardiomyopathy Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy.Hypertrophic cardiomyopathy: from mutation to functional analysis of defective protein It's never too early to look: subclinical disease in sarcomeric dilated cardiomyopathy.Two strikes and you're out: gene-gene mutation interactions in HCM.From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy.Mitochondrial DNA analysis by multiplex denaturing high-performance liquid chromatography and selective sequencing in pediatric patients with cardiomyopathy.Solitary papillary muscle hypertrophy: a new echo-electrocardiographic syndrome? A case report.Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.Functional consequences of hypertrophic and dilated cardiomyopathy-causing mutations in alpha-tropomyosin.Hypertrophic cardiomyopathy with little hypertrophy and severe arrhythmia

P2860

Q26999424-7D03553C-0305-4645-8293-11CBBC663AF7 Q28276100-FC2632C0-5909-4E75-BE40-6CB1C3126A8B Q28283579-B9CB0729-0ECB-41CF-A6C4-30FDCD16F1BF Q28301903-129D41B4-69AC-4377-B5CA-55205E6C2DD0 Q28307606-FFF89E94-D8FE-4087-A373-378122A6E666 Q28472836-CD779E06-1A1E-4348-926A-444C0EEC3EE0 Q31158025-CE21B8E8-E046-46E8-8CB6-2E8018B11069 Q33158326-5D54763E-EF54-4F2B-9CBD-A917264FE666 Q33930898-440DFB68-1DD7-4278-973A-9F71B8F663BA Q34445272-752C9C48-5408-4C2D-A741-F7F62E39403F Q34627407-D44EC79C-404F-4FCF-B66F-3C450FC6CE61 Q34999606-ABFD5E82-5471-4D65-90D9-D8F23F70B041 Q35581582-226365F9-1DBD-434D-B6AE-FACA3601C582 Q35721684-4EBF8B04-5419-4627-A9B9-688241132ACD Q35762855-399BC220-D8BC-49A9-AB5E-2DC40D0A0BD6 Q35812684-0C5C4635-7B8E-4311-B0E4-9D453AF9F818 Q36178742-B0AF223F-E667-4E74-A808-EE44C8314526 Q36625673-EC4EDB08-E937-44CD-9D3F-ACB34FB61AF8 Q36686074-8EA1A847-029E-49EF-B2E2-2DA8E33554DF Q37255253-B0ACD6EF-A129-4F63-8091-DF92D69BC19D Q37284441-49DB26DA-1BA9-4408-B44C-DCAC2FEB2C82 Q37314360-1605F8A0-F1FC-4249-8635-944DDFA9EF4D Q37603719-065BF4BF-EB27-4027-8388-933F3235C2E0 Q37666010-9A679BBF-E787-4C70-A4EA-279CA3930383 Q38108764-777C405A-92B5-47ED-82DE-5A2E274F42E1 Q38441528-C6A304C7-4648-42BD-86B7-63EDA073C6F5 Q38724869-FC025724-EAD3-4FC2-B462-A8F3974EEF48 Q39617071-3241DD0F-8BDD-4572-B884-A92FC2121629 Q41958589-221041D1-B8B9-4E8B-85F7-6A090DFCB3A9 Q41993268-1D7471BC-DE38-40AF-B7D0-9DECB1972365 Q42619125-EF7B6815-C57A-42DE-A355-CCB3C134312A Q42722256-49F9470F-3F65-465A-AD2E-17A67D3AF0BA Q43014048-00CD8C83-2D94-4D0F-BE7C-FB808ECE8AFB Q45985544-5096E0C2-426C-498F-9F6A-652466A9F4E6 Q46649582-6641F1FE-1FA8-428F-8791-155904FBD2BD Q48177445-1127713B-D2D3-4B79-B61D-AF7EE9C6E080 Q51389950-D5348D21-C122-4777-BF6B-EB566F7D9B91 Q58565572-813F5BD5-0C85-40D3-B334-A142E22D33AC

P2860

Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy

http://www.wikidata.org/entity/Q28216997

description

2002 nî lūn-bûn

@nan

2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@ast

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@en

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@nl

type

label

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@ast

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@en

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@nl

prefLabel

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@ast

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@en

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@nl

P1433

Q28216997-F0FBAD44-37B3-455F-BEAF-6B0633FDBAAB

P1476

Q28216997-38A0FECF-98E2-4B35-A8E3-9507F5AE8260

P2093

Q28216997-14BBE398-9694-4773-A440-2C31B1A13390

Q28216997-17C2B4AC-6C2F-4714-99E7-467EECDD073D

Q28216997-23313DD7-B1D4-49D7-A4AF-7F4E591EDBC4

Q28216997-5F7A8079-034A-4A18-A1A9-5AD21E3C8FCE

Q28216997-64E49B3E-67D9-4291-A972-EFAEBAEA83C5

Q28216997-BA33808A-3FB2-4D35-A52B-440989F4A54B

Q28216997-FA218547-AC1C-44C1-B045-23F85C370F42

Q28216997-FAB08982-BE11-4069-853F-7A82C42046A4

P304

Q28216997-A5617B7C-9552-488D-8695-1CFD054129BB

P31

Q28216997-725B633E-99A9-4F1B-9B81-024A02092E8B

P356

Q28216997-9F063373-C50E-4689-B41D-CDBA1652D58D

P407

Q28216997-75991D19-8686-4EC2-BD91-AA9B0FABB8BD

P433

Q28216997-680290D1-71EF-4BF2-A7AC-BB72EAD638B4

P478

Q28216997-E0AF2ABA-FAA8-4C05-B6A3-EC072CF3F961

P577

Q28216997-0357512F-3E84-449F-B2CB-BE3F06195A92

P5875

Q28216997-9D66BF68-AC29-4D26-80F1-59FE6663A85C

P698

Q28216997-18398303-7FD2-42A5-8178-A177B1287727

P356

01.CIR.0000042675.59901.14

P1433

P1476

Prevalence and severity of "be ...... in hypertrophic cardiomyopathy

@en

P2093

A Jamil Tajik

http://www.w3.org/2001/XMLSchema#string

Bernard J Gersh

http://www.w3.org/2001/XMLSchema#string

Melissa L Will

http://www.w3.org/2001/XMLSchema#string

Michael J Ackerman

http://www.w3.org/2001/XMLSchema#string

Rameen Shakur

http://www.w3.org/2001/XMLSchema#string

Rick A Nishimura

http://www.w3.org/2001/XMLSchema#string

Sara L Van Driest

http://www.w3.org/2001/XMLSchema#string

Steve R Ommen

http://www.w3.org/2001/XMLSchema#string

P304

3085-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000042675.59901.14

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10997627

http://www.w3.org/2001/XMLSchema#string

P698

12473556

http://www.w3.org/2001/XMLSchema#string